Sample size calculation in hierarchical

coefficient of variation controlled effect interaction test linear mixed model marginal effect power analysis

Journal

Statistics in medicine
ISSN: 1097-0258
Titre abrégé: Stat Med
Pays: England
ID NLM: 8215016

Informations de publication

Date de publication:
20 02 2022
Historique:
revised: 19 11 2021
received: 04 02 2021
accepted: 25 11 2021
pubmed: 4 1 2022
medline: 1 4 2022
entrez: 3 1 2022
Statut: ppublish

Résumé

Motivated by a suicide prevention trial with hierarchical treatment allocation (cluster-level and individual-level treatments), we address the sample size requirements for testing the treatment effects as well as their interaction. We assume a linear mixed model, within which two types of treatment effect estimands (controlled effect and marginal effect) are defined. For each null hypothesis corresponding to an estimand, we derive sample size formulas based on large-sample z-approximation, and provide finite-sample modifications based on a t-approximation. We relax the equal cluster size assumption and express the sample size formulas as functions of the mean and coefficient of variation of cluster sizes. We show that the sample size requirement for testing the controlled effect of the cluster-level treatment is more sensitive to cluster size variability than that for testing the controlled effect of the individual-level treatment; the same observation holds for testing the marginal effects. In addition, we show that the sample size for testing the interaction effect is proportional to that for testing the controlled or the marginal effect of the individual-level treatment. We conduct extensive simulations to validate the proposed sample size formulas, and find the empirical power agrees well with the predicted power for each test. Furthermore, the t-approximations often provide better control of type I error rate with a small number of clusters. Finally, we illustrate our sample size formulas to design the motivating suicide prevention factorial trial. The proposed methods are implemented in the R package H2x2Factorial.

Identifiants

pubmed: 34978097
doi: 10.1002/sim.9284
pmc: PMC8962918
mid: NIHMS1763126
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

645-664

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

© 2022 John Wiley & Sons Ltd.

Références

Psychiatr Serv. 2013 Dec 1;64(12):1195-202
pubmed: 24036589
J Stat Plan Inference. 2018 Mar;194:106-121
pubmed: 29358843
Biometrics. 2020 Dec;76(4):1064-1074
pubmed: 31872435
Int J Epidemiol. 2006 Oct;35(5):1292-300
pubmed: 16943232
Stat Med. 2005 Sep 15;24(17):2583-96
pubmed: 16118812
Stat Med. 2007 Jun 15;26(13):2589-603
pubmed: 17094074
Stat Med. 2020 Dec 10;39(28):4218-4237
pubmed: 32823372
J Am Acad Child Adolesc Psychiatry. 2009 Oct;48(10):1005-1013
pubmed: 19730273
Stat Med. 2016 Oct 30;35(24):4320-4334
pubmed: 27271007
Biometrics. 2018 Dec;74(4):1450-1458
pubmed: 29921006
Am J Prev Med. 2014 Oct;47(4):498-504
pubmed: 25092122
Trials. 2016 Feb 09;17:72
pubmed: 26862034
Stat Med. 2001 Feb 15;20(3):377-90
pubmed: 11180308
BMC Med Res Methodol. 2015 Apr 23;15:38
pubmed: 25899170
Stat Med. 2010 Jun 30;29(14):1488-501
pubmed: 20101669
BMC Med Res Methodol. 2003 Nov 24;3:26
pubmed: 14633287
J Clin Epidemiol. 2014 Oct;67(10):1083-92
pubmed: 25063555
Pilot Feasibility Stud. 2019 Oct 10;5:115
pubmed: 31624637
JAMA. 2003 May 21;289(19):2545-53
pubmed: 12759326
Eur Heart J. 1994 May;15(5):585-8
pubmed: 8055995
BMJ. 2011 Sep 26;343:d5886
pubmed: 21948873
Eval Rev. 2003 Feb;27(1):79-103
pubmed: 12568061
J Clin Epidemiol. 2018 Apr;96:120-125
pubmed: 29113938
Am J Public Health. 2017 Jul;107(7):1078-1086
pubmed: 28520480
Stat Med. 2018 Jan 15;37(1):12-27
pubmed: 28948651
Psychol Methods. 2012 Jun;17(2):153-75
pubmed: 22309956
Stat Med. 2007 Mar 15;26(6):1181-92
pubmed: 16927251
J Clin Epidemiol. 2020 Jan;117:52-59
pubmed: 31585174
Stat Med. 2010 Sep 20;29(21):2169-79
pubmed: 20687162

Auteurs

Zizhong Tian (Z)

Department of Biostatistics, Yale University School of Public Health, New Haven, Connecticut, USA.

Denise Esserman (D)

Department of Biostatistics, Yale University School of Public Health, New Haven, Connecticut, USA.
Yale Center for Analytical Sciences, Yale University, New Haven, Connecticut, USA.

Guangyu Tong (G)

Department of Biostatistics, Yale University School of Public Health, New Haven, Connecticut, USA.
Yale Center for Analytical Sciences, Yale University, New Haven, Connecticut, USA.

Ondrej Blaha (O)

Department of Biostatistics, Yale University School of Public Health, New Haven, Connecticut, USA.
Yale Center for Analytical Sciences, Yale University, New Haven, Connecticut, USA.

James Dziura (J)

Department of Biostatistics, Yale University School of Public Health, New Haven, Connecticut, USA.
Yale Center for Analytical Sciences, Yale University, New Haven, Connecticut, USA.

Peter Peduzzi (P)

Department of Biostatistics, Yale University School of Public Health, New Haven, Connecticut, USA.
Yale Center for Analytical Sciences, Yale University, New Haven, Connecticut, USA.

Fan Li (F)

Department of Biostatistics, Yale University School of Public Health, New Haven, Connecticut, USA.
Yale Center for Analytical Sciences, Yale University, New Haven, Connecticut, USA.
Center for Methods in Implementation and Prevention Science, Yale University, New Haven, Connecticut, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH